Class I · High risk
Morphine Sulfate Extended Release tablet
Labeling: Label mix-up; Bottles labeled to contain Morphine Sulfate IR may contain Morphine Sulfate ER and vice-versa.
FDA Drug Recalls
14,806 recalls, newest first
Class II · Moderate risk
Procrit (epoetin alfa)
Presence of Particulate Matter: glass delamination
Class II · Moderate risk
Eye Drops advanced relief
Labeling: Label Mix-Up: Incorrect back labeling of the immediate container of eye drops (unit carton and front label are correct) which do not list three active ingredients: Dextran 70, PEG 400, and povidone.
Class II · Moderate risk
Leflunomide tablets
Subpotent (Single Ingredient Drug): Distribution of product that did not meet specifications.
Class II · Moderate risk
Leflunomide tablets
Subpotent (Single Ingredient Drug): Distribution of product that did not meet specifications.
Class I · High risk
Merit Convenience Kits containing Cytosol Ophthalmics Balanced Salt Solution
Lack of Assurance of Sterility: Procedure kits contain a balanced salt solution that may be contaminated with endotoxins.